The NHS is increasingly facing issues of patient backlog due to capacity constraints and the impact of COVID-19. In response to this, Novartis has partnered with Cievert to use their PROMs-based solution – Penguin patient management system, that can benefit patients and the healthcare system. The introduction of Penguin within dermatology and/or rheumatology NHS service is proposed through Joint Working, a non-promotional activity focused on patient benefit.

Discover more about this customisable digital platform and how it could enable rapid assessment of patient need to help prioritise treatment and free up hospital capacity.

 

 

 

See how the Penguin patient management system works, how easy it is for your team to collect the bespoke information they need and how it could empower patients to be more involved in their treatment.

 

 

 

This demonstration video shows you how to use the Penguin management system to monitor patients remotely and tailor questionnaires specifically to them so you only collect the data you need.

 

 
Rate this content: 
0
No votes yet
UK | September 2021 | 147686

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Novartis via [email protected] or online through the pharmacovigilance intake (PVI) tool at www.report.novartis.com
If you have a question about the product, please contact Medical Information on 01276 698370 or by email at [email protected]